by GlobeNewsWire | Dec 29, 2015 | Globe Newswire
NEW YORK, Dec. 29, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative diseases including...
by editor | Dec 9, 2015 | Blog, Buzz
[cmwizard menu=avxlmenu title=”Full Coverage AVXL”/] Yes, the Buzz is strong today for Anavex Life Sciences Corp. (NASDAQ: AVXL). So far we have seen the stock as high as $7.14. While volume is light, it was only held back, in our opinion, by the...
by GlobeNewsWire | Dec 2, 2015 | Globe Newswire
[cmwizard menu=avxlmenu title=”Full Coverage AVXL”/]NEW YORK, Dec. 02, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat...
by GlobeNewsWire | Nov 30, 2015 | Globe Newswire
[cmwizard menu=avxlmenu title=”Full Coverage AVXL”/]NEW YORK, Nov. 30, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat...
by editor | Nov 23, 2015 | Buzz, Feature Box
The Buzz is picking up big time for Anavex Life Sciences (Nasdaq: AVXL), as the stock begins to move up after recent highs of over $14. Let’s look at this Buzz![cmwizard menu=avxlmenu title=”Full Coverage AVXL”/]Bringing the Elections into the...